-
Product Insights
Rubella (German Measles) – Drugs In Development, 2023
Global Markets Direct’s, ‘Rubella (German Measles) - Drugs In Development, 2023’, provides an overview of the Rubella (German Measles) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Rubella (German Measles), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Rubivirus Infections – Drugs In Development, 2023
Global Markets Direct’s, ‘Rubivirus Infections - Drugs In Development, 2023’, provides an overview of the Rubivirus Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Rubivirus Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Measles – Drugs In Development, 2023
Global Markets Direct’s, ‘Measles - Drugs In Development, 2023’, provides an overview of the Measles pipeline landscape. The report provides comprehensive information on the therapeutics under development for Measles, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Yellow Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Yellow Fever – Drugs In Development, 2022, provides an overview of the Yellow Fever (Infectious Disease) pipeline landscape. Yellow fever is an acute systemic illness (hemorrhagic fever) caused by the Flavivirus. It is spread by mosquitoes. Symptoms include irregular heartbeats, bleeding, vomiting, coma, delirium, fever, headache and muscle aches. There is no specific treatment for yellow fever but can be treated to relieve the symptoms. Report Highlights Global Markets Direct's...
-
Product Insights
Yellow Fever Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Yellow Fever Global Clinical Trials Review, H2, 2018" provides an overview of Yellow Fever clinical trials scenario. This report provides top line data relating to the clinical trials on Yellow Fever. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
Brazil In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others.
GlobalData’s “Brazil In Vitro Diagnostics Market Outlook to 2025” is a comprehensive databook report, covering key market data on the Brazil In Vitro Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cardiac Disease, Clinical Chemistry, Hematological Disorders, Hormonal Disorders, Infectious Disease, IVD Analyzers and Reagents, Metabolic Disorder, Oncology and Women's Health. The Brazil In Vitro Diagnostics Market report provides key information and data on: • Annualized market revenues (USD), volume...
-
Sector Analysis
Brazil Infectious Disease Market Outlook to 2025
GlobalData’s “Brazil Infectious Disease Market Outlook to 2025” is a comprehensive databook report, covering key market data on the Brazil Infectious Disease market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Chlamydia Trachomatis Tests, Clostridium difficile Tests, Cytomegalovirus (CMV) Tests, Hepatitis Tests, Human Immunodeficiency Virus (HIV) Tests, Human Papilloma Virus (HPV) Tests, Human T-Lymphotropic Virus (HTLV) Tests, Multi-parameter Chlamydia Trachomatis and Neisseria Gonorrhoeae NAATs, Multi-parameter HIV, Hepatitis B, and Hepatitis C Nucleic...